Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2017 |
Jun. 30, 2016 |
Jun. 30, 2017 |
Jun. 30, 2016 |
|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Loss (gain) due to change in value of note payable | $ (13) | $ (67) | $ 219 | $ (101) |
Gain (loss) due to expiration of warrant liability | 577 | 0 | $ (6,717) | 17 |
VenturEast | BioServe | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Number of shares associated with notes payable (in shares) | 84,278 | |||
Loss (gain) due to change in value of note payable | (13) | $ (67) | $ 219 | (101) |
2016 Offering | Significant Unobservable Inputs (Level 3) | Fair value measurements, recurring | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Gain (loss) due to expiration of warrant liability | $ 577 | $ (6,717) | $ 17 |
X | ||||||||||
- Definition Business Combination, Consideration Transferred, Notes Payable in Shares No definition available.
|
X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|